Indian Journal of Pharmacology Home 

SHORT COMMUNICATION
[View FULLTEXT] [Download PDF]
Year : 2011  |  Volume : 43  |  Issue : 2  |  Page : 207--209

Safety of single-dose nevirapine for prevention of vertical transmission of human immunodeficiency virus infection

Mangala Bhaskar Murthy1, Bhaskar Krishnamurthy2 
1 Department of Pharmacology, Government Medical College, Miraj, India
2 Department of Obstetrics and Gynecology, Government Medical College, Miraj, India

Correspondence Address:
Mangala Bhaskar Murthy
Department of Pharmacology, Government Medical College, Miraj
India

Introduction : Nevirapine administered as a single dose each to the mother and child within 72 h after birth is used to prevent vertical transmission of human immunodeficiency virus (HIV) under the prevention of parent to child transmission of HIV program (PPTCT). The efficacy of nevirapine in this regard has been proved beyond doubt, but there are unresolved questions about its safety. Hence, the primary objective of this study was to evaluate the safety of this regime. Materials and Methods : HIV-positive pregnant women who consented to participate in the study received a single oral dose of 200 mg nevirapine at the onset of labor followed by administration of 2 mg/kg of nevirapine syrup to the newborn within 72 h of birth. Both mother and child were followed up for 1 week postpartum to note the occurrence of any adverse reactions. Results : The mother and child followed up for 1 week postpartum did not show any serious adverse reactions in the present study. Mothers reported adverse reactions like nausea, vomiting, and headache which were self-limiting and did not require any intervention. Conclusion : The present study substantiates the safety of nevirapine.


How to cite this article:
Murthy MB, Krishnamurthy B. Safety of single-dose nevirapine for prevention of vertical transmission of human immunodeficiency virus infection.Indian J Pharmacol 2011;43:207-209


How to cite this URL:
Murthy MB, Krishnamurthy B. Safety of single-dose nevirapine for prevention of vertical transmission of human immunodeficiency virus infection. Indian J Pharmacol [serial online] 2011 [cited 2021 Sep 24 ];43:207-209
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=2011;volume=43;issue=2;spage=207;epage=209;aulast=Murthy;type=0